Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020072942 - METHODS TO TREAT RENAL DISORDERS USING CALCIUM CHANNEL INHIBITORS

Publication Number WO/2020/072942
Publication Date 09.04.2020
International Application No. PCT/US2019/054767
International Filing Date 04.10.2019
IPC
A61K 35/12 2015.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
A61K 31/437 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
CPC
A61K 31/437
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
437the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61K 35/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Applicants
  • THE TRUSTEES OF INDIANA UNIVERSITY [US]/[US]
Inventors
  • BASILE, David, P.
  • MEHROTRA, Purvi
  • STUREK, Michael, S.
Agents
  • ASTIN, Joshua, P.
  • REEVES, Charles, R.
  • HENRY, Thomas, Q.
  • MCNETT, John, C.
  • WAGNER, Vincent, O.
Priority Data
62/741,30204.10.2018US
62/876,18619.07.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS TO TREAT RENAL DISORDERS USING CALCIUM CHANNEL INHIBITORS
(FR) PROCÉDÉS DE TRAITEMENT DE TROUBLES RÉNAUX UTILISANT DES INHIBITEURS DE CANAUX CALCIQUES
Abstract
(EN)
Disclosed are methods to treat a renal disorder in a mammal in need thereof by administering to the mammal in need of treatment an effective amount of a store operated calcium entry (SOCE) inhibitor or a pharmaceutically acceptable salt thereof.
(FR)
L'invention concerne des procédés de traitement d'un trouble rénal chez un mammifère le nécessitant par administration au mammifère nécessitant un traitement d'une quantité efficace d'un inhibiteur d'entrée de calcium actionnée selon la réserve (SOCE) ou d'un sel pharmaceutiquement acceptable de celui-ci.
Latest bibliographic data on file with the International Bureau